Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Mark Boguniewicz

Concepts (542)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dermatitis, Atopic
169
2026
322
25.010
 Why?
Antibodies, Monoclonal, Humanized
25
2026
992
3.100
 Why?
Eczema
14
2023
66
2.880
 Why?
Severity of Illness Index
53
2026
2930
2.130
 Why?
Antibodies, Monoclonal
10
2025
1505
2.030
 Why?
Skin
34
2024
753
1.770
 Why?
Tacrolimus
20
2023
196
1.620
 Why?
Biological Products
3
2024
257
1.600
 Why?
Asthma
19
2025
1797
1.510
 Why?
Pruritus
17
2026
59
1.470
 Why?
Dermatologic Agents
14
2024
68
1.380
 Why?
Quality of Life
31
2025
3204
1.360
 Why?
Staphylococcus aureus
15
2024
451
1.320
 Why?
Practice Guidelines as Topic
11
2025
1581
1.260
 Why?
Staphylococcal Skin Infections
8
2018
40
1.220
 Why?
Immunosuppressive Agents
15
2024
838
1.200
 Why?
Double-Blind Method
29
2025
2062
1.080
 Why?
Keratinocytes
12
2024
249
1.000
 Why?
Receptors, Aryl Hydrocarbon
2
2024
60
0.980
 Why?
Calcineurin Inhibitors
14
2010
69
0.870
 Why?
Immunoglobulin E
19
2024
315
0.860
 Why?
Kaposi Varicelliform Eruption
12
2013
21
0.850
 Why?
Humans
188
2026
145474
0.850
 Why?
Treatment Outcome
35
2026
11772
0.710
 Why?
Cytokines
17
2024
2067
0.690
 Why?
Administration, Topical
17
2026
153
0.680
 Why?
Boron Compounds
3
2018
29
0.680
 Why?
Urticaria
3
2008
38
0.660
 Why?
Emollients
4
2018
11
0.660
 Why?
Hypersensitivity
3
2023
254
0.660
 Why?
Interleukin-4 Receptor alpha Subunit
1
2020
9
0.650
 Why?
Adrenal Cortex Hormones
11
2023
484
0.640
 Why?
Intermediate Filament Proteins
7
2018
57
0.630
 Why?
Janus Kinase Inhibitors
3
2025
28
0.620
 Why?
Allergy and Immunology
2
2017
43
0.580
 Why?
Bridged Bicyclo Compounds, Heterocyclic
3
2018
280
0.580
 Why?
Bandages
3
2016
41
0.580
 Why?
Dermatology
3
2017
130
0.580
 Why?
Anti-Infective Agents
5
2022
232
0.580
 Why?
Expert Testimony
1
2019
42
0.560
 Why?
Anti-Inflammatory Agents
11
2020
477
0.560
 Why?
Skin Care
4
2008
22
0.550
 Why?
Adult
77
2025
40777
0.550
 Why?
Interleukin-13
11
2025
146
0.550
 Why?
Antimicrobial Cationic Peptides
6
2010
81
0.540
 Why?
Interferon-gamma
11
2013
784
0.540
 Why?
Food Hypersensitivity
6
2024
164
0.540
 Why?
Biological Therapy
1
2017
28
0.520
 Why?
Occlusive Dressings
1
2016
7
0.500
 Why?
Psoriasis
12
2023
115
0.490
 Why?
Aminopyridines
3
2026
129
0.480
 Why?
Benzamides
3
2026
226
0.480
 Why?
Anti-Asthmatic Agents
1
2019
260
0.470
 Why?
Interleukin-4
9
2023
207
0.470
 Why?
Phosphodiesterase 4 Inhibitors
2
2026
12
0.460
 Why?
Herpes Simplex
3
2013
99
0.460
 Why?
Comorbidity
8
2025
1661
0.450
 Why?
Advisory Committees
1
2017
229
0.450
 Why?
Child, Preschool
34
2026
11853
0.450
 Why?
Desensitization, Immunologic
5
2024
89
0.440
 Why?
Education, Medical, Continuing
1
2016
133
0.430
 Why?
Epidermis
3
2017
156
0.420
 Why?
Cost of Illness
9
2018
324
0.420
 Why?
beta-Defensins
8
2010
22
0.410
 Why?
Adolescent
39
2025
22529
0.410
 Why?
Simplexvirus
3
2011
82
0.400
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
3
2018
15
0.400
 Why?
Glycyrrhetinic Acid
3
2008
7
0.400
 Why?
Conjunctivitis
3
2023
30
0.400
 Why?
Th2 Cells
6
2017
175
0.400
 Why?
Child
44
2024
22707
0.390
 Why?
Anti-Allergic Agents
3
2014
40
0.390
 Why?
Administration, Cutaneous
10
2026
127
0.380
 Why?
Molecular Targeted Therapy
2
2020
439
0.380
 Why?
Hypersensitivity, Immediate
3
2019
41
0.380
 Why?
Autoimmune Diseases
4
2018
468
0.370
 Why?
Calcineurin
5
2006
105
0.370
 Why?
Histamine H1 Antagonists
3
2026
24
0.360
 Why?
Male
60
2026
72842
0.350
 Why?
Immunity, Innate
6
2011
835
0.330
 Why?
Allergens
7
2023
386
0.330
 Why?
Anti-Inflammatory Agents, Non-Steroidal
4
2015
345
0.330
 Why?
Histamine Antagonists
2
2026
21
0.320
 Why?
Female
58
2026
78844
0.320
 Why?
Drug Approval
3
2020
93
0.310
 Why?
Ointments
10
2016
25
0.310
 Why?
Adaptive Immunity
1
2011
167
0.310
 Why?
Plant Extracts
3
2008
188
0.310
 Why?
Clinical Trials as Topic
4
2020
1061
0.300
 Why?
Infant
24
2024
10077
0.300
 Why?
Complementary Therapies
1
2010
95
0.290
 Why?
Staphylococcal Infections
4
2023
391
0.290
 Why?
Dietary Fats
2
2008
308
0.290
 Why?
Off-Label Use
2
2020
51
0.280
 Why?
Disease Progression
6
2019
2864
0.280
 Why?
Drug Hypersensitivity
3
1995
90
0.280
 Why?
Methicillin-Resistant Staphylococcus aureus
1
2012
251
0.280
 Why?
Receptors, IgE
1
2008
43
0.280
 Why?
Population Groups
2
2018
56
0.280
 Why?
Chronic Disease
12
2019
1808
0.270
 Why?
Prevalence
12
2019
2865
0.260
 Why?
Middle Aged
39
2025
36215
0.260
 Why?
Biomarkers
8
2024
4295
0.260
 Why?
Inflammation
4
2018
2878
0.260
 Why?
Disease Management
5
2020
653
0.260
 Why?
Self Report
7
2019
870
0.260
 Why?
Pyrimidines
4
2024
530
0.250
 Why?
United States
20
2024
16098
0.240
 Why?
Sulfonamides
4
2023
583
0.240
 Why?
Rhinitis, Allergic
2
2024
42
0.240
 Why?
Chemokine CCL17
2
2024
6
0.230
 Why?
Consensus
3
2024
477
0.230
 Why?
Dermatitis, Allergic Contact
2
2016
73
0.220
 Why?
Cross-Sectional Studies
14
2021
5904
0.220
 Why?
Patch Tests
3
2016
60
0.220
 Why?
Vaccinia virus
4
2011
35
0.220
 Why?
Omalizumab
2
2020
43
0.220
 Why?
Anti-Bacterial Agents
6
2023
1923
0.220
 Why?
Sphingosine N-Acyltransferase
1
2024
6
0.220
 Why?
Phototherapy
3
2018
49
0.210
 Why?
Steroids
3
2017
160
0.210
 Why?
Exanthema
1
2005
86
0.210
 Why?
Diagnosis, Differential
7
2008
1508
0.210
 Why?
Ectropion
1
2023
1
0.200
 Why?
Randomized Controlled Trials as Topic
7
2026
1747
0.200
 Why?
Pyrazoles
2
2024
517
0.200
 Why?
Janus Kinases
1
2023
21
0.200
 Why?
Down-Regulation
7
2017
618
0.190
 Why?
Membrane Proteins
5
2024
1164
0.190
 Why?
Blepharitis
1
2023
9
0.190
 Why?
Pain
2
2019
789
0.190
 Why?
Drug Administration Schedule
6
2026
782
0.190
 Why?
Young Adult
13
2025
14218
0.190
 Why?
Anxiety
3
2019
1118
0.190
 Why?
Sublingual Immunotherapy
1
2022
4
0.190
 Why?
Drug Industry
2
2018
49
0.190
 Why?
Receptors, Interleukin
3
2020
43
0.180
 Why?
Animals
17
2024
38030
0.180
 Why?
Tight Junctions
3
2011
82
0.180
 Why?
Sickness Impact Profile
2
2019
62
0.180
 Why?
Cefuroxime
1
2001
5
0.180
 Why?
Cyclopropanes
3
2026
84
0.170
 Why?
Recurrence
4
2019
1138
0.170
 Why?
Skin Cream
3
2026
11
0.170
 Why?
Cephalosporins
1
2001
45
0.170
 Why?
STAT6 Transcription Factor
3
2011
24
0.170
 Why?
Autoantibodies
1
2008
1509
0.160
 Why?
Depression
3
2019
1546
0.160
 Why?
Evidence-Based Medicine
3
2024
740
0.160
 Why?
Bacterial Toxins
3
2012
108
0.160
 Why?
Patient Education as Topic
5
2015
777
0.160
 Why?
Patient Reported Outcome Measures
5
2024
497
0.150
 Why?
Injections, Subcutaneous
4
2023
170
0.150
 Why?
Sleep Initiation and Maintenance Disorders
1
2022
195
0.150
 Why?
Vaccines
1
2024
388
0.140
 Why?
Skin Diseases, Infectious
3
2008
13
0.140
 Why?
Phosphodiesterase Inhibitors
1
2018
73
0.140
 Why?
Patient Health Questionnaire
1
2018
40
0.140
 Why?
Injections
1
2019
199
0.140
 Why?
Gene Expression Regulation
7
2011
2597
0.130
 Why?
Genetic Predisposition to Disease
6
2011
2378
0.130
 Why?
Surveys and Questionnaires
5
2019
6066
0.130
 Why?
Guidelines as Topic
2
2018
266
0.130
 Why?
Immunologic Factors
2
2005
260
0.130
 Why?
T-Lymphocytes
6
2006
1996
0.130
 Why?
Skin Diseases
1
2019
152
0.130
 Why?
Sleep Wake Disorders
1
2021
314
0.120
 Why?
Skin Diseases, Viral
2
2018
6
0.120
 Why?
Drug Therapy, Combination
4
2026
1044
0.120
 Why?
Gloves, Surgical
1
1996
4
0.120
 Why?
Latex
1
1996
9
0.120
 Why?
Gloves, Protective
1
1996
3
0.120
 Why?
Rubber
1
1996
8
0.120
 Why?
Personal Satisfaction
1
2018
219
0.120
 Why?
Cells, Cultured
13
2011
4148
0.120
 Why?
Practice Patterns, Physicians'
2
2017
1371
0.120
 Why?
Dermatitis, Occupational
1
1996
16
0.120
 Why?
Bronchial Hyperreactivity
1
1996
104
0.120
 Why?
Chemokines, CC
3
2006
33
0.110
 Why?
Receptors, Cytokine
2
2010
36
0.110
 Why?
Milk Proteins
1
2015
33
0.110
 Why?
Milk Hypersensitivity
1
2015
18
0.110
 Why?
T-Lymphocyte Subsets
2
2011
418
0.110
 Why?
Patient Acceptance of Health Care
2
2019
881
0.110
 Why?
Primary Health Care
2
2016
1735
0.110
 Why?
Infant Formula
1
2015
71
0.110
 Why?
Hydrotherapy
1
2014
7
0.110
 Why?
Patient-Centered Care
2
2018
547
0.100
 Why?
Skin Tests
3
2012
94
0.100
 Why?
Clinical Decision-Making
1
2018
363
0.100
 Why?
Gene Expression Profiling
4
2011
1767
0.100
 Why?
Patient Care Planning
1
2015
170
0.100
 Why?
Ambulatory Care
1
2019
609
0.100
 Why?
HLA-B7 Antigen
1
2013
7
0.100
 Why?
Recombinant Proteins
6
2006
1368
0.100
 Why?
Dose-Response Relationship, Drug
5
2020
2028
0.100
 Why?
Algorithms
3
2018
1845
0.100
 Why?
Clinical Trials, Phase III as Topic
2
2024
116
0.100
 Why?
Risk Factors
8
2015
10885
0.100
 Why?
Health Status
1
2018
832
0.090
 Why?
Cholecalciferol
1
2013
61
0.090
 Why?
Logistic Models
4
2019
2134
0.090
 Why?
Delphi Technique
2
2024
332
0.090
 Why?
RNA, Messenger
10
2007
2803
0.090
 Why?
Lipids
1
2017
707
0.090
 Why?
Interferon Regulatory Factor-2
1
2011
3
0.090
 Why?
Eosinophils
3
2024
316
0.090
 Why?
Vitamins
1
2013
182
0.090
 Why?
Immunity, Cellular
1
2013
274
0.090
 Why?
Aged
13
2019
26153
0.090
 Why?
Fibronectins
2
2023
136
0.090
 Why?
Research Design
1
2018
1137
0.090
 Why?
Vitamin D
2
2013
403
0.080
 Why?
Mice, Transgenic
3
2011
2188
0.080
 Why?
Polymorphism, Single Nucleotide
7
2011
2158
0.080
 Why?
Physical Therapy Modalities
1
2014
336
0.080
 Why?
Pharmaceutical Vehicles
2
2008
12
0.080
 Why?
Guideline Adherence
1
2015
586
0.080
 Why?
Glucocorticoids
2
2013
531
0.080
 Why?
Th1-Th2 Balance
1
2010
8
0.080
 Why?
JNK Mitogen-Activated Protein Kinases
1
2011
153
0.080
 Why?
Signal Transduction
2
2023
5216
0.080
 Why?
CD4-Positive T-Lymphocytes
3
2010
1140
0.080
 Why?
Receptors, Chemokine
1
2010
48
0.080
 Why?
Therapies, Investigational
1
2010
18
0.080
 Why?
Chickenpox Vaccine
1
2010
76
0.080
 Why?
Receptors, Interleukin-7
1
2010
28
0.080
 Why?
Cathelicidins
5
2010
40
0.080
 Why?
Hypertension
1
2018
1273
0.070
 Why?
Herpesviridae Infections
1
2010
148
0.070
 Why?
Genetic Variation
2
2011
972
0.070
 Why?
Cardiovascular Diseases
2
2018
2187
0.070
 Why?
Adjuvants, Immunologic
3
2004
243
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2011
749
0.070
 Why?
Age Factors
4
2019
3342
0.070
 Why?
Coal Tar
1
2008
2
0.070
 Why?
Keratolytic Agents
1
2008
5
0.070
 Why?
Dietary Supplements
1
2013
583
0.070
 Why?
Mice
9
2012
18329
0.070
 Why?
Cell Degranulation
1
2008
40
0.070
 Why?
Pediatrics
2
2015
1121
0.070
 Why?
Disease Outbreaks
1
2012
419
0.070
 Why?
Polymorphism, Genetic
1
2011
614
0.070
 Why?
Pyroglyphidae
2
2022
18
0.070
 Why?
Basophils
1
2008
52
0.070
 Why?
Irritants
1
2008
42
0.070
 Why?
S100 Proteins
1
2008
35
0.070
 Why?
Dosage Forms
1
2008
11
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2011
1217
0.070
 Why?
Phenotype
4
2023
3155
0.070
 Why?
United Kingdom
2
2019
344
0.070
 Why?
Aged, 80 and over
6
2019
8333
0.060
 Why?
Environmental Exposure
1
2012
578
0.060
 Why?
Combined Modality Therapy
3
2014
1266
0.060
 Why?
Reference Values
2
2019
798
0.060
 Why?
CD8-Positive T-Lymphocytes
1
2013
919
0.060
 Why?
Protein Precursors
1
2007
136
0.060
 Why?
Macrophage Inflammatory Proteins
1
2006
11
0.060
 Why?
Herpesvirus 3, Human
1
2010
343
0.060
 Why?
Mast Cells
1
2008
147
0.060
 Why?
Immunohistochemistry
6
2010
1716
0.060
 Why?
Clinical Protocols
1
2008
280
0.060
 Why?
Quality Improvement
1
2016
1295
0.060
 Why?
Cromolyn Sodium
1
2026
6
0.060
 Why?
Disease Susceptibility
2
2020
344
0.060
 Why?
Patient Dropouts
1
2007
65
0.060
 Why?
Drug Combinations
3
2020
396
0.060
 Why?
Cost-Benefit Analysis
3
2018
639
0.060
 Why?
Nonprescription Drugs
1
2007
69
0.060
 Why?
Emergency Service, Hospital
1
2019
2381
0.060
 Why?
Lymphocyte Activation
3
2010
1132
0.060
 Why?
Antibodies, Anti-Idiotypic
1
2006
50
0.060
 Why?
Receptors, Lymphocyte Homing
1
2006
15
0.060
 Why?
Virus Replication
2
2006
521
0.060
 Why?
Proteins
2
2010
1023
0.060
 Why?
Gene Frequency
3
2013
487
0.060
 Why?
Conjunctivitis, Allergic
1
2025
4
0.060
 Why?
Immunoglobulins
2
2005
162
0.060
 Why?
Thiazoles
1
2006
141
0.060
 Why?
Thyroid Diseases
1
2005
44
0.050
 Why?
Models, Immunological
1
2005
99
0.050
 Why?
L-Lactate Dehydrogenase
1
2024
112
0.050
 Why?
Interleukins
1
2006
248
0.050
 Why?
Academies and Institutes
1
2004
61
0.050
 Why?
Resorcinols
1
2023
6
0.050
 Why?
Immunoglobulin G
2
2023
892
0.050
 Why?
Conflict of Interest
1
2004
54
0.050
 Why?
Stilbenes
1
2023
30
0.050
 Why?
Gene Expression
4
2007
1476
0.050
 Why?
Hyaluronic Acid
1
2006
226
0.050
 Why?
Lactams
2
1995
28
0.050
 Why?
Statistics, Nonparametric
2
2019
428
0.050
 Why?
Interleukin-10
1
2005
309
0.050
 Why?
Janus Kinase 1
1
2023
26
0.050
 Why?
Leukocyte Count
2
1995
316
0.050
 Why?
Nitriles
1
2024
207
0.050
 Why?
Interleukin-11
1
2003
10
0.050
 Why?
Acute Disease
6
2008
1036
0.050
 Why?
STAT Transcription Factors
1
2023
25
0.050
 Why?
Risk
2
2018
919
0.050
 Why?
Membrane Glycoproteins
1
2006
499
0.050
 Why?
Prednisone
2
1994
224
0.050
 Why?
Dermatophagoides pteronyssinus
1
2022
3
0.050
 Why?
Patient Compliance
1
2007
587
0.050
 Why?
Respiratory Sounds
1
2023
103
0.050
 Why?
Azetidines
1
2022
45
0.050
 Why?
Patient Care Team
1
2008
696
0.050
 Why?
Clinical Trials, Phase II as Topic
1
2022
75
0.050
 Why?
Interleukin-17
1
2003
120
0.050
 Why?
Granuloma, Respiratory Tract
1
2002
13
0.050
 Why?
Insurance, Physician Services
1
2002
4
0.050
 Why?
Baths
1
2022
14
0.050
 Why?
Leukocytes, Mononuclear
3
2013
574
0.040
 Why?
Langerhans Cells
1
2001
12
0.040
 Why?
3',5'-Cyclic-AMP Phosphodiesterases
1
2001
8
0.040
 Why?
Prognosis
3
2018
4316
0.040
 Why?
North America
1
2022
302
0.040
 Why?
Lymphoma
2
2018
237
0.040
 Why?
Superantigens
1
2001
70
0.040
 Why?
Ceramides
1
2022
117
0.040
 Why?
Purines
1
2022
187
0.040
 Why?
Interleukin-15
1
2002
95
0.040
 Why?
Prospective Studies
2
2020
8057
0.040
 Why?
Immunotherapy
1
2006
666
0.040
 Why?
Claudin-1
2
2011
17
0.040
 Why?
Prodrugs
1
2001
52
0.040
 Why?
Time Factors
2
2007
7123
0.040
 Why?
Beryllium
1
2002
161
0.040
 Why?
Bacterial Adhesion
1
2001
108
0.040
 Why?
Antigens, Bacterial
1
2001
126
0.040
 Why?
Placebos
1
2021
193
0.040
 Why?
Caregivers
2
2023
1073
0.040
 Why?
Disease Models, Animal
1
2011
4560
0.040
 Why?
Monocyte Chemoattractant Proteins
1
2000
7
0.040
 Why?
Diet
2
2022
1277
0.040
 Why?
Bayes Theorem
1
2022
420
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
3
2011
848
0.040
 Why?
Fibrinogen
1
2001
180
0.040
 Why?
Health Expenditures
1
2002
194
0.040
 Why?
Longitudinal Studies
2
2019
2953
0.040
 Why?
Injection Site Reaction
1
2020
4
0.040
 Why?
Markov Chains
2
2015
132
0.040
 Why?
Chemokines, CXC
2
2003
68
0.040
 Why?
Leg Dermatoses
1
2019
1
0.040
 Why?
Scalp Dermatoses
1
2019
4
0.040
 Why?
Foot Dermatoses
1
2019
4
0.040
 Why?
Buttocks
1
2019
14
0.040
 Why?
Hand Dermatoses
1
2019
7
0.040
 Why?
Facial Dermatoses
1
2019
17
0.040
 Why?
Bronchoalveolar Lavage Fluid
3
2002
638
0.040
 Why?
Biopsy
4
2007
1082
0.040
 Why?
Genetic Association Studies
2
2011
369
0.040
 Why?
Genitalia
1
2019
33
0.040
 Why?
Smallpox Vaccine
2
2011
23
0.040
 Why?
Fatty Acids
1
2022
457
0.040
 Why?
Risk Assessment
2
2019
3747
0.040
 Why?
Interleukin-16
1
1998
6
0.040
 Why?
Torso
1
2019
36
0.040
 Why?
Haplotypes
2
2011
499
0.040
 Why?
Skin Diseases, Bacterial
1
2018
22
0.040
 Why?
Autoantigens
1
2001
427
0.040
 Why?
Infection Control
1
2020
173
0.040
 Why?
Dysbiosis
1
2020
187
0.040
 Why?
Association
1
2018
12
0.040
 Why?
Phthalic Acids
1
2018
42
0.040
 Why?
Thalidomide
1
2018
43
0.040
 Why?
Acetamides
1
2018
41
0.030
 Why?
Rhinitis, Allergic, Seasonal
1
2018
25
0.030
 Why?
Arm
1
2019
110
0.030
 Why?
Canada
1
2020
431
0.030
 Why?
Colony Count, Microbial
1
2018
89
0.030
 Why?
Herpesvirus 2, Human
2
2009
27
0.030
 Why?
Age Distribution
1
2018
403
0.030
 Why?
Sex Distribution
1
2018
387
0.030
 Why?
Medicaid
1
2002
467
0.030
 Why?
Fundoplication
1
1997
52
0.030
 Why?
Immune System
1
2018
180
0.030
 Why?
Quinazolines
1
2018
266
0.030
 Why?
United States Food and Drug Administration
1
2018
208
0.030
 Why?
Peak Expiratory Flow Rate
2
1993
25
0.030
 Why?
Psychiatric Status Rating Scales
1
2019
531
0.030
 Why?
Monocytes
2
2002
539
0.030
 Why?
Pilot Projects
2
1995
1891
0.030
 Why?
Educational Status
1
2019
466
0.030
 Why?
Forced Expiratory Volume
2
1997
450
0.030
 Why?
Texas
2
2008
272
0.030
 Why?
Proteomics
1
2023
1188
0.030
 Why?
Interleukin-12
1
1996
115
0.030
 Why?
Health Occupations
1
1996
36
0.030
 Why?
Genetic Linkage
1
1996
272
0.030
 Why?
Vaccination
1
2024
1426
0.030
 Why?
Whey Proteins
1
2015
9
0.030
 Why?
Psychometrics
1
2019
731
0.030
 Why?
Penicillins
1
1995
62
0.030
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
977
0.030
 Why?
Gastroesophageal Reflux
1
1997
237
0.030
 Why?
Multivariate Analysis
1
2019
1547
0.030
 Why?
Legionellosis
1
1994
2
0.030
 Why?
Legionnaires' Disease
1
1994
4
0.030
 Why?
Nebulizers and Vaporizers
1
1995
62
0.030
 Why?
Anaphylaxis
1
1996
102
0.030
 Why?
Dermatitis, Irritant
2
2004
12
0.030
 Why?
Intraoperative Complications
1
1996
157
0.030
 Why?
Milk
1
2015
119
0.030
 Why?
Polymerase Chain Reaction
2
2010
1041
0.030
 Why?
Pneumonia, Pneumocystis
1
1994
34
0.030
 Why?
Methylprednisolone
1
1994
59
0.030
 Why?
Pyridines
1
2018
609
0.030
 Why?
Socioeconomic Factors
1
2019
1323
0.030
 Why?
Attention Deficit Disorder with Hyperactivity
1
2018
429
0.030
 Why?
Feasibility Studies
1
2018
1111
0.030
 Why?
Antigens
1
1996
348
0.030
 Why?
Long-Term Care
1
2015
118
0.030
 Why?
Cohort Studies
2
2015
6013
0.030
 Why?
Respiratory Physiological Phenomena
1
1993
35
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1995
161
0.030
 Why?
Sleep
1
2021
888
0.020
 Why?
ROC Curve
1
2015
617
0.020
 Why?
Immunologic Memory
1
1996
368
0.020
 Why?
Chemokine CXCL10
2
2009
39
0.020
 Why?
Case-Control Studies
2
2013
3623
0.020
 Why?
Mice, Inbred BALB C
2
2006
1261
0.020
 Why?
Sex Factors
1
2019
2105
0.020
 Why?
Genotype
1
2018
1852
0.020
 Why?
Interdisciplinary Communication
1
2014
200
0.020
 Why?
Laparoscopy
1
1997
481
0.020
 Why?
Chemokines
2
2006
217
0.020
 Why?
Respiratory System
1
1993
150
0.020
 Why?
Cockroaches
1
2012
23
0.020
 Why?
Treatment Failure
1
1993
360
0.020
 Why?
Haptens
1
1992
25
0.020
 Why?
Healthcare Disparities
1
2019
735
0.020
 Why?
Cats
1
2012
231
0.020
 Why?
Models, Theoretical
1
2015
558
0.020
 Why?
Patient Care
1
2013
119
0.020
 Why?
Vaccinia
1
2011
20
0.020
 Why?
Reproducibility of Results
1
2019
3413
0.020
 Why?
Mice, Knockout
2
2011
3124
0.020
 Why?
Microbiota
1
2019
730
0.020
 Why?
Enterocolitis, Pseudomembranous
1
1991
29
0.020
 Why?
Receptors, Interferon
1
2011
60
0.020
 Why?
Lung Diseases
1
1997
780
0.020
 Why?
Dogs
1
2012
458
0.020
 Why?
Fluorescent Antibody Technique
1
2011
365
0.020
 Why?
Family
1
2015
682
0.020
 Why?
Predictive Value of Tests
1
2015
2121
0.020
 Why?
Antigens, Viral
1
2010
182
0.020
 Why?
Cell Line
2
2008
2823
0.020
 Why?
Chemokine CCL27
1
2009
1
0.020
 Why?
Health Care Costs
2
2003
425
0.020
 Why?
DNA Mutational Analysis
1
2010
407
0.020
 Why?
Mutation
2
2011
4075
0.020
 Why?
Incidence
1
1996
2923
0.020
 Why?
Age of Onset
1
2010
555
0.020
 Why?
Interferon-beta
1
2009
92
0.020
 Why?
Lung
1
2002
4106
0.020
 Why?
Skin Physiological Phenomena
1
2008
24
0.020
 Why?
Herpesvirus 1, Human
1
2009
84
0.020
 Why?
Hospitalization
1
2019
2460
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
105
0.020
 Why?
Glyceraldehyde-3-Phosphate Dehydrogenases
1
2007
12
0.020
 Why?
Fluticasone
1
2007
53
0.020
 Why?
Androstadienes
1
2007
75
0.020
 Why?
Chemokine CCL20
1
2006
5
0.020
 Why?
In Situ Hybridization
2
1998
318
0.020
 Why?
Thiazolidines
1
2006
13
0.010
 Why?
Toll-Like Receptor 3
1
2006
30
0.010
 Why?
Health Personnel
1
2013
754
0.010
 Why?
Apoptosis
1
1995
2440
0.010
 Why?
Vitis
1
2006
28
0.010
 Why?
Antigens, Differentiation, T-Lymphocyte
1
2006
104
0.010
 Why?
Europe
1
2006
418
0.010
 Why?
Analysis of Variance
1
2008
1300
0.010
 Why?
Obesity
1
2018
3116
0.010
 Why?
Antibodies, Viral
1
2009
674
0.010
 Why?
Product Surveillance, Postmarketing
1
2005
74
0.010
 Why?
Erythema
1
2004
28
0.010
 Why?
Neoplasms, Experimental
1
2005
167
0.010
 Why?
Genomics
1
2010
825
0.010
 Why?
Case Management
1
2004
68
0.010
 Why?
Antigens, Neoplasm
1
2006
271
0.010
 Why?
DNA, Viral
1
2006
356
0.010
 Why?
Inflammation Mediators
1
2006
506
0.010
 Why?
Rats
1
2012
5584
0.010
 Why?
Collagen Type III
1
2003
15
0.010
 Why?
Infant, Newborn
1
2015
6447
0.010
 Why?
Retreatment
1
2003
79
0.010
 Why?
Dendritic Cells
1
2006
499
0.010
 Why?
Base Sequence
1
2006
2170
0.010
 Why?
Genes, T-Cell Receptor beta
1
2002
23
0.010
 Why?
Collagen Type I
1
2003
143
0.010
 Why?
Immunoblotting
1
2002
295
0.010
 Why?
Insurance, Health, Reimbursement
1
2003
98
0.010
 Why?
Transforming Growth Factor beta1
1
2003
177
0.010
 Why?
Health Services
1
2003
113
0.010
 Why?
Societies, Medical
1
2006
899
0.010
 Why?
Calcium
1
2008
1190
0.010
 Why?
Immunophenotyping
1
2003
319
0.010
 Why?
Administration, Oral
1
2004
866
0.010
 Why?
Biopsy, Needle
1
2002
185
0.010
 Why?
Cooperative Behavior
1
2004
462
0.010
 Why?
Chemotactic Factors, Eosinophil
1
2000
7
0.010
 Why?
Up-Regulation
1
2003
847
0.010
 Why?
Chemokine CCL11
1
2000
25
0.010
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
334
0.010
 Why?
Cell Adhesion Molecules
1
2001
181
0.010
 Why?
Transforming Growth Factor beta
1
2003
474
0.010
 Why?
Extracellular Matrix Proteins
1
2001
156
0.010
 Why?
Cell Differentiation
1
2008
2046
0.010
 Why?
Patient Satisfaction
1
2004
709
0.010
 Why?
Odds Ratio
1
2003
1082
0.010
 Why?
Drug Prescriptions
1
2002
288
0.010
 Why?
Receptors, Interleukin-5
1
1998
4
0.010
 Why?
Receptors, Interleukin-12
1
1998
6
0.010
 Why?
Receptors, Interleukin-4
1
1998
16
0.010
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
1998
17
0.010
 Why?
Amino Acid Sequence
1
2002
2129
0.010
 Why?
Flow Cytometry
1
2002
1162
0.010
 Why?
Molecular Sequence Data
1
2002
2883
0.010
 Why?
Cell Movement
1
2002
959
0.010
 Why?
Models, Biological
1
2004
1764
0.010
 Why?
Retrospective Studies
2
2006
17291
0.010
 Why?
Colorado
1
2006
4553
0.010
 Why?
Respiratory Function Tests
1
1997
544
0.010
 Why?
Immunocompetence
1
1994
46
0.010
 Why?
Interleukin-5
1
1994
39
0.010
 Why?
Methacholine Chloride
1
1993
51
0.010
 Why?
Bronchial Provocation Tests
1
1993
47
0.010
 Why?
Fatal Outcome
1
1994
305
0.010
 Why?
Aerosols
1
1993
145
0.010
 Why?
Interleukin-8
1
1993
269
0.010
 Why?
Macrophage Activation
1
1993
181
0.010
 Why?
Administration, Inhalation
1
1993
571
0.010
 Why?
Bronchi
1
1993
263
0.010
 Why?
Cell Survival
1
1995
1100
0.010
 Why?
Enterotoxins
1
1991
89
0.010
 Why?
Macrophages, Alveolar
1
1993
373
0.010
 Why?
Antibodies, Bacterial
1
1991
147
0.000
 Why?
Immunoglobulins, Intravenous
1
1991
133
0.000
 Why?
Interleukin-1
1
1993
961
0.000
 Why?
Neoplasms
1
2005
2906
0.000
 Why?
Transcription, Genetic
1
1993
1454
0.000
 Why?
Boguniewicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (542) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)